SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-042312
Filing Date
2019-07-29
Accepted
2019-07-29 16:42:12
Documents
2
Period of Report
2019-07-23

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1510
2 EX-24 ex-24.htm EX-24 8591
  Complete submission text file 0001104659-19-042312.txt   11579
Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139
Business Address
Arbuckle Stuart A (Reporting) CIK: 0001557290 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38223 | Film No.: 19981687

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations